Yarnton, United Kingdom

Mary F Fitzgerald



Average Co-Inventor Count = 10.4

ph-index = 6

Forward Citations = 84(Granted Patents)


Location History:

  • Begbroke, GB (1996 - 1997)
  • Begbroke Oxford, GB (2002 - 2004)
  • Oxon, GB (2005)
  • Yarton, GB (2006)
  • Yarnton, Oxfordshire, GB (2006)
  • Oxfordshire, GB (2006)
  • Oxford, GB (2007 - 2010)
  • Yarnton, GB (2001 - 2012)

Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: Mary F Fitzgerald: Pioneering Innovator in Pharmaceutical Sciences

Introduction:

Mary F Fitzgerald, a prolific inventor based in Yarnton, GB, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 18 patents, her groundbreaking inventions have focused on developing novel compounds for various medical applications.

Latest Patents:

1. "I-phenyl 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use": This patent revolves around 4-cyanophenyl, 2-sulfanyl, 1-phenyl pyrimidine derivatives, essential in treating chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development.

2. "Dihydropyridine derivatives for use as human neutrophil elastase inhibitors": Fitzgerald's innovative dihydropyridine derivatives have paved the way for medicaments treating chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development.

Career Highlights:

Mary F Fitzgerald has honed her craft at renowned companies such as Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. Her expertise and dedication to advancing pharmaceutical research have led to groundbreaking discoveries in the industry, revolutionizing treatment options for various critical conditions.

Collaborations:

Throughout her illustrious career, Mary F Fitzgerald has collaborated with esteemed professionals in the field, including Karl-Heinz Schlemmer and Graham Sturton. Together, they have synergized their efforts to push the boundaries of pharmaceutical innovation, fostering a culture of excellence and creativity.

Conclusion:

In conclusion, Mary F Fitzgerald stands out as a trailblazing inventor whose relentless pursuit of scientific excellence has revolutionized the pharmaceutical landscape. Her remarkable patents and collaborative spirit underscore her as a pioneering figure in the field of pharmaceutical sciences, shaping the future of healthcare and improving countless lives worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…